Arthritis Ireland’s Governance & Management – a letter from our CEO John Church.

In light of the recent media coverage, it is important as Chief Executive of this great organisation, I share with you the lengths to which we go to ensure we are fully compliant with all legal and regulatory requirements and that we exercise good governance at all times.

You can download our impact report below to see exactly where our money came from in 2015, and exactly where it was spent.

Arthritis Ireland is a limited company with charity status, which means that we are subject to all the rigour and rules imposed by the Companies Registration Office. As a charity, committed to operating to the highest standards of good practice and transparency, we are also happy to confirm that we welcome and are signed-up to the following codes of practice – the Code of Governance for Type C organisations, the Statement of Guiding Principles for Fundraising, the Statement of Recommended Practice for accounting and reporting, the Regulation of Lobbying Act 2015 and the Charities Regulatory Authority.

Arthritis Ireland is governed by a Board of Directors who give their time freely and generously to further the cause. A full list of our Board Directors can be found by clicking here. Arthritis Ireland has a designated Governance sub-committee, who deal with all elements of the audit, finance, and remuneration of employees. Ernst & Young (EY), one of the leading auditors in Ireland, produce a set of annual accounts. Accounts for the last number of years can be found here. http://bit.ly/2a8FtbA

There is more detail regarding our governance and management on our website, along with a detailed 2015 Impact Report outlining our impact in the community which you can access here. You will also find all of our salary information through this page.http://bit.ly/2au8ZrL

Thank you for your on-going support and commitment to Arthritis Ireland. None of what we do could happen without our members, fundraisers, volunteers, staff and board who support the organisation in so many ways.

Together, I look forward to continuing our fight against arthritis in 2016.
John Church
CEO